Cure My Disease

Don't miss your cure!

 Log in / Sign up

Learning to fall safely: treadmill training could reduce falls in MS

NCT ID NCT06919900

Recruiting now Prevention Sponsor: Georgia State University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether people with multiple sclerosis can learn to prevent falls by practicing on a treadmill that unexpectedly slips or trips. 64 participants aged 45 and older will be split into two groups: one gets the slip-and-trip training, the other just walks on the treadmill. The goal is to see if this training helps them react better to real-life stumbles and reduce fall risk.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Perturbation training (slip and trip exposure on a treadmill)
What this could lead to
If it works, this could lead to a new fall-prevention exercise program for people with multiple sclerosis, helping them stay safer and more independent.
What could go wrong
This is a small, early-stage study with only 64 people. It tests a training method, not a drug, so results may not apply to everyone with MS. The training involves unexpected slips and trips, which carries a risk of falling despite safety harnesses.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS, RELAPSING-REMITTING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

multiple sclerosis relapsing-remitting multiple sclerosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MULTIPLE SCLEROSIS, RELAPSING-REMITTING

Contacts and locations

Locations

  • Georgia State University Biomechanics Lab

    RECRUITING

    Atlanta, Georgia, 30303, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.